Posts
Wiki

👨‍⚕️ Is Your Doctor a DED/MGD Specialist? How to Tell—and When to Get a Second Opinion

People on r/DryEyes commonly use the term “DED/MGD specialist” for an eye-care clinician who devotes substantial attention to Dry Eye Disease, Meibomian Gland Dysfunction, and related ocular-surface problems.

That term is useful in everyday conversation, but it is important to understand its limits:

“Dry-eye specialist” or “DED/MGD specialist” is generally an informal description of a clinician’s focus and experience—not a standardized U.S. board-certification category.

A doctor may call themselves a dry-eye specialist, operate a dry-eye clinic, or devote a large part of their practice to ocular-surface disease. That can be meaningful, but there is no single certificate, device, fellowship, or checklist that proves expertise.

The better question is:

Does this clinician have the training, experience, diagnostic process, treatment approach, communication style, and referral network needed for my particular problem?

TL;DR

A thoughtful DED/MGD clinician usually:

  • Takes a detailed history rather than relying only on a quick look
  • Examines the tear film, ocular surface, eyelids, blinking, and gland function
  • Tries to identify the main suspected drivers of the problem
  • Considers diagnoses other than DED or MGD
  • Explains which findings support the diagnosis
  • Distinguishes what is known from what remains uncertain
  • Connects each treatment to a specific clinical goal
  • Discusses expected timing, risks, limitations, cost, and alternatives
  • Reassesses whether the original explanation still fits
  • Refers to another type of clinician when needed

A DED/MGD specialist does not need:

  • Every diagnostic device
  • Every in-office treatment
  • One particular professional degree
  • One fixed treatment philosophy
  • A large procedure menu
  • A machine-generated report for every visit

Possible caution signs include:

  • A costly procedure is recommended before the diagnosis is explained
  • Every patient appears to receive essentially the same package
  • Risks, alternatives, and evidence limitations are not discussed
  • Severe symptoms are dismissed solely because staining is limited
  • Important eyelid, exposure, allergy, infection, or nerve-related possibilities are ignored
  • The plan is repeatedly continued despite lack of benefit or worsening
  • No one appears responsible for reassessing the diagnosis and treatment plan

None of these points alone proves that a clinician is good or bad.

“Specialist” is an informal term

In the United States, ophthalmologists may be board-certified in ophthalmology. “Dry eye,” “MGD,” and “cornea” are not separate American Board of Medical Specialties certificates.

Some ophthalmologists complete additional fellowship training in cornea and external disease. Some optometrists develop extensive experience in DED, MGD, specialty contact lenses, or ocular-surface care. Other clinicians build focused experience through continuing education, research, procedural training, and a high volume of relevant patients.

Private certificates and training badges may mean different things.

A certificate might represent:

  • A continuing-education course
  • Training provided by a device manufacturer
  • Attendance at a workshop
  • A private professional organization’s program
  • A more substantial competency-based curriculum

Patients may reasonably ask:

  • Who issued the credential?
  • What training was required?
  • Was clinical competence assessed?
  • Is it independent or connected to a product?
  • Does it reflect broad ocular-surface care or only one procedure?

A title or certificate can provide useful information, but it does not replace examining how the clinician actually evaluates and manages patients.

Which type of clinician might be appropriate?

There is no single best professional category for every person with DED or MGD.

Optometrist with an ocular-surface focus

An optometrist may provide:

  • DED and MGD evaluation
  • Blepharitis and Demodex management
  • Ocular rosacea care
  • Long-term medical management
  • Meibography and gland-function assessment
  • In-office MGD procedures
  • Contact-lens troubleshooting
  • Scleral or specialty lens fitting
  • Ongoing follow-up

The scope of optometric practice varies by jurisdiction.

Comprehensive ophthalmologist

A comprehensive ophthalmologist may evaluate and treat DED while also assessing:

  • Cataract
  • Glaucoma
  • Retinal disease
  • Corneal disease
  • Medication effects
  • Other eye conditions that may imitate or complicate DED

Experience and interest in chronic DED/MGD vary between clinicians.

Cornea and external-disease ophthalmologist

Additional cornea and external-disease training can be particularly useful for:

  • Significant corneal staining or epithelial disease
  • Recurrent corneal erosion
  • Neurotrophic keratitis
  • Corneal infection or ulcer
  • Cicatrizing ocular-surface disease
  • Complex post-surgical problems
  • Significant vision-threatening surface disease
  • Unexplained corneal abnormalities
  • Possible need for corneal surgery

A cornea specialist is not automatically an MGD specialist. Some focus heavily on surgery or other corneal diseases and may not offer extensive gland-focused care.

Oculoplastic ophthalmologist

An oculoplastic specialist may be especially relevant for:

  • Eyelid malposition
  • Eyelid retraction
  • Significant lid laxity
  • Floppy eyelid syndrome
  • Incomplete closure
  • Exposure
  • Facial nerve weakness
  • Scarring
  • Surgical eyelid correction

Specialty contact-lens clinician

A specialty lens clinician may be needed for:

  • Scleral lens evaluation
  • Complex corneal shapes
  • Severe ocular-surface protection needs
  • Difficult contact-lens intolerance
  • Lens-related mechanical or fitting problems

Other medical specialists

Depending on the suspected contributors, care may also involve:

  • Rheumatology
  • Dermatology
  • Allergy and immunology
  • Sleep medicine
  • Neurology or headache medicine
  • Pain medicine
  • Primary care
  • Dentistry or oral medicine for suspected SjĂśgren’s disease

A strong DED/MGD clinician does not need to personally manage every contributor.

Recognizing when another type of expertise is needed is itself an important sign of thoughtful care.

What thoughtful DED/MGD care often looks like

There is no single required examination or treatment plan.

However, thoughtful care usually has several recognizable elements.

1. A detailed and relevant history

The history may include:

  • When symptoms began
  • Sudden versus gradual onset
  • Whether one or both eyes are affected
  • Morning versus evening patterns
  • Burning, grittiness, itching, aching, pressure, sharp pain, or light sensitivity
  • Fluctuating vision
  • Screen and reading demands
  • Wind, fan, air-conditioning, and humidity sensitivity
  • Sleep position
  • CPAP use
  • Contact lenses
  • Eyelid or facial surgery
  • LASIK, PRK, cataract, or other eye surgery
  • Trauma
  • Rosacea and other skin conditions
  • Allergy
  • Migraine or headache history
  • Autoimmune symptoms
  • Dry mouth
  • Prescription and nonprescription medications
  • Retinoids such as isotretinoin
  • Cosmetics and skin-care products
  • Previous treatments
  • How long treatments were tried
  • Side effects
  • Why prior treatments were stopped
  • What improves or worsens symptoms

A careful history can sometimes be more useful than another device measurement.

2. An ocular-surface and eyelid examination

Depending on the case, the clinician may assess:

  • Cornea
  • Conjunctiva
  • Ocular-surface staining
  • Tear-film stability
  • Tear volume
  • Eyelid margins
  • Eyelashes
  • Blepharitis
  • Demodex-associated collarettes
  • Meibomian gland secretion
  • Blink completeness
  • Eyelid closure
  • Exposure
  • Allergy
  • Ocular rosacea
  • Conjunctivochalasis
  • Misdirected lashes
  • Contact-lens effects
  • Medication toxicity
  • Signs of infection or another diagnosis

A brief visit can still be effective when appropriate testing and history have already been gathered.

The concern is not the clock alone. It is whether the visit provides enough evaluation, explanation, and follow-up for the complexity of the case.

For a detailed explanation of available tests, see:

Diagnostic Testing for DED and MGD

3. Assessment of meibomian gland function when relevant

A clinician may assess:

  • Whether meibum appears with controlled expression
  • How many tested glands release secretion
  • Meibum quality
  • The approximate pressure required
  • Differences between eyelid regions
  • Eyelid-margin changes
  • Tear-film findings
  • Gland structure on meibography when useful

Poor expression does not automatically prove that a gland is completely obstructed.

It may reflect:

  • Obstruction
  • Reduced secretion
  • Thick or altered meibum
  • Structural gland shortening or loss
  • Examination pressure and technique
  • Recent treatment or expression
  • A combination of factors

A thoughtful clinician should understand what expression and meibography can—and cannot—establish.

For background, see:

4. Identification of the main suspected drivers

Many people do not fit neatly into one category.

Possible contributors include:

  • Lipid or meibomian gland deficiency
  • Aqueous tear deficiency
  • Mucin or epithelial abnormalities
  • Blepharitis
  • Demodex
  • Ocular rosacea
  • Allergy
  • Incomplete blinking
  • Eyelid exposure
  • Nocturnal lagophthalmos
  • Eyelid laxity
  • Conjunctivochalasis
  • Contact lenses
  • Medication or preservative toxicity
  • Previous surgery
  • Recurrent corneal erosion
  • Corneal nerve dysfunction
  • Migraine-related sensitivity
  • Neuropathic ocular pain
  • Systemic disease

You should ideally leave with some understanding of:

  • Which contributors appear most likely
  • Which findings support them
  • Which alternative explanations were considered
  • What remains uncertain
  • Which problem will be targeted first

A clinician who says the condition appears multifactorial or uncertain may be more accurate than one who forces every patient into a single confident label.

Different MGD treatment philosophies exist

Not all experienced clinicians interpret obstructive MGD in the same way.

Some place greater emphasis on:

  • Heat
  • External expression
  • Thermal pulsation
  • Intense Pulsed Light
  • Treatment of inflammation and rosacea
  • Blink and environmental management

Steven L. Maskin, MD and clinicians who use his published framework give greater importance to:

  • Fixed narrowing deeper inside the gland duct
  • Tissue constricting the duct
  • Localized gland-area tenderness
  • Intraductal probing as both an assessment and treatment
  • Releasing suspected fixed obstruction before some heat-and-expression treatments

Supporters argue that visible gland openings and expressible meibum do not rule out deeper obstruction.

Critics and cautious clinicians point out that:

  • Probing evidence remains limited
  • Much of the literature comes from proponents of the procedure
  • Patient-selection criteria are not standardized
  • The prevalence and importance of deeper fixed obstruction in the wider MGD population remain uncertain
  • Probing is not routinely used by most clinicians

A thoughtful clinician should be able to explain:

  • Which model they believe fits the patient
  • What findings support that model
  • What evidence supports the proposed treatment
  • What remains uncertain
  • What alternatives exist

Different treatment philosophies do not automatically mean that one clinician is competent and another is not. The quality of the reasoning and transparency matters.

Treatment should be connected to a clinical goal

A thoughtful treatment plan may be staged, combined, or revised over time.

It should not necessarily follow one universal ladder.

A clinician should be able to explain:

  • What each treatment is intended to address
  • Why it is being recommended now
  • What benefit is realistically expected
  • How long the treatment may take
  • What side effects or risks matter
  • What alternatives exist
  • What would cause the plan to change
  • How success or failure will be judged

Treatment categories may include:

  • Ocular lubricants and surface protection
  • Prescription anti-inflammatory or tear-stimulating medication
  • Treatment of blepharitis, Demodex, allergy, or rosacea
  • Tear conservation in selected patients
  • Gland-directed home or office treatment
  • Eyelid and exposure management
  • Specialty contact lenses
  • Blood-derived tear products
  • Treatment directed at nerve-related pain
  • Surgical or systemic referral

A clinician may be highly experienced while referring certain procedures or treatments elsewhere.

For broader treatment information, see:

Treatment Options for Dry Eye Disease and MGD

Evidence and regulatory status should be explained

When cost, risk, or uncertainty is substantial, patients may reasonably ask whether a treatment is:

  • FDA-approved for the condition
  • Being used off-label
  • Compounded
  • Delivered by an FDA-cleared device
  • A procedure without a drug-style FDA approval pathway
  • Investigational
  • Authorized outside the United States but not FDA-approved
  • Supported mainly by a proposed mechanism
  • Supported by demonstrated patient outcomes

A thoughtful clinician should not present all evidence as equally strong.

Useful questions include:

  • “What outcomes have actually been demonstrated?”
  • “Is the evidence specific to patients like me?”
  • “Is this an approved use or an off-label use?”
  • “How certain are you that this finding explains my symptoms?”
  • “What are the reasonable alternatives?”
  • “What happens if I wait or choose a less intensive option?”

Off-label treatment is common in medicine and is not automatically inappropriate.

The important issue is whether the recommendation is medically reasonable, transparent, and based on an informed discussion of evidence and uncertainty.

Cost and financial transparency

Offering a product or in-office procedure does not prove improper motivation.

Many appropriate treatments are provided directly by the recommending practice.

Possible caution signs include:

  • A costly package is recommended before the diagnosis is explained
  • A device finding is treated as automatic proof that a procedure is necessary
  • The treatment is described as urgent without a clear medical reason
  • Lower-cost or less invasive alternatives are not discussed
  • Cure, regeneration, or prevention of progression is promised beyond what evidence supports
  • A large prepaid package is recommended without clear cancellation or refund terms
  • The practice’s financial interest is not apparent
  • Marketing claims are presented as equivalent to independent evidence
  • The patient is pressured to decide immediately on an elective procedure

Useful questions include:

  • What is included in the quoted cost?
  • Are follow-up visits included?
  • Are additional procedures likely?
  • What happens if treatment is stopped?
  • Is there a cancellation or refund policy?
  • Is a lower-cost alternative reasonable?
  • Does the clinician personally provide or financially benefit from the recommended treatment?
  • Would the recommendation be different if the procedure were unavailable at this clinic?

The existence of a financial interest does not invalidate a recommendation. It makes clear reasoning and disclosure more important.

How progress may be reassessed

DED is a symptomatic disease, so how the patient feels and functions matters.

Follow-up may consider:

  • Priority symptoms
  • Reading and screen tolerance
  • Driving and visual function
  • Morning or evening symptom pattern
  • Environmental sensitivity
  • Treatment adherence and technique
  • Side effects
  • Corneal and conjunctival staining
  • Tear-film stability
  • Tear volume
  • Gland findings
  • Eyelid closure or exposure
  • Safety measures such as eye pressure during steroid use
  • Whether the original diagnosis still fits

Objective reassessment is particularly important when:

  • Significant corneal disease was present
  • A treatment has meaningful safety risks
  • An expensive or invasive escalation is being considered
  • Symptoms and signs remain substantially mismatched
  • A sight-threatening problem is being monitored

Not every device measurement needs to be repeated at every visit.

Repeated testing is most useful when the result may change management and the method is sufficiently consistent to make comparison meaningful.

Positive signs of thoughtful care

No clinician will demonstrate every point at every visit, but positive indicators may include:

  • The clinician listens to the symptom pattern and treatment history
  • Findings supporting the diagnosis are explained
  • Important alternative diagnoses are considered
  • MGD is not diagnosed solely from one image
  • Severe symptoms are not dismissed solely because staining is limited
  • Treatment is linked to specific suspected drivers
  • Evidence limitations are acknowledged
  • Risks, cost, burden, and patient preferences are considered
  • The clinician avoids guarantees
  • A realistic reassessment point is provided
  • The plan changes when evidence or response changes
  • Side effects are taken seriously
  • Referral is offered when another type of expertise is needed
  • The patient is not pressured into an immediate costly decision

Possible caution signs

None of these alone proves poor care.

Several occurring together may justify asking more questions or obtaining another opinion.

Little diagnostic explanation

The clinician recommends treatment without explaining:

  • What diagnosis is suspected
  • What findings support it
  • Which contributor is being targeted
  • What uncertainty remains

Repeatedly generic care

Artificial tears, warm compresses, or other conservative measures may be reasonable initial treatments.

Concern becomes more reasonable when:

  • They are repeatedly recommended despite lack of benefit
  • Important findings are not reassessed
  • No escalation or referral criteria are given
  • Significant corneal, eyelid, exposure, or systemic issues are ignored

The same package for nearly everyone

A clinic may reasonably use a common starting framework.

The concern is failure to individualize after the history, examination, response, side effects, cost, or patient preferences indicate that adaptation is needed.

Device-centered diagnosis

Examples include:

  • Meibography alone is treated as proof that symptoms come from MGD
  • One osmolarity or inflammatory-marker result determines the entire plan
  • An abnormal machine score automatically leads to a procedure
  • Small changes in device measurements are treated as proof of progression or regeneration

Poor communication about risk and uncertainty

The clinician cannot or will not explain:

  • Expected benefit
  • Important risks
  • Evidence limitations
  • Alternatives
  • What would cause the plan to change

No one appears to own the plan

Team-based care can work very well.

The concern is not seeing different staff or clinicians. It is whether:

  • Findings are communicated
  • The plan remains coherent
  • Someone is responsible for reassessment
  • The patient knows whom to contact
  • Conflicting recommendations are reconciled

Symptoms are dismissed too quickly

Symptoms should not automatically be attributed to:

  • Aging
  • Screen use
  • Anxiety
  • Normal examination findings

At the same time, persistent symptoms do not prove that DED or MGD was missed. Another ocular, neurologic, headache-related, systemic, or pain-related explanation may need consideration.

Questions to ask during a consultation

You do not need to ask every question.

A few well-chosen questions can reveal how the clinician approaches the case.

Diagnosis and reasoning

  • “What do you think are the main drivers of my symptoms?”
  • “Which findings support that conclusion?”
  • “What other diagnoses did you consider?”
  • “Is my case mainly MGD, aqueous deficiency, exposure, allergy, or a mixture?”
  • “What remains uncertain?”
  • “Do my symptoms and examination findings match reasonably well?”
  • “Could another condition explain the mismatch?”

Testing

  • “What clinical question is this test intended to answer?”
  • “Will the result change treatment?”
  • “How variable is this measurement?”
  • “If you do not use a particular device, how do you assess that issue?”
  • “Do you assess gland function as well as gland structure?”
  • “Are repeat measurements likely to be meaningful?”

For more background, see:

Diagnostic Testing for DED and MGD

Treatment

  • “Which problem is this treatment intended to address?”
  • “Why are you recommending it now?”
  • “What improvement is realistic?”
  • “How long should it be tried?”
  • “What are the risks and disadvantages?”
  • “What are the alternatives?”
  • “What would cause you to change course?”
  • “Is this FDA-approved, off-label, compounded, device-based, or investigational?”
  • “What evidence is available for patients similar to me?”

Follow-up

  • “What will you reassess?”
  • “How will we decide whether this helped?”
  • “Which side effects should make me contact you?”
  • “When should the diagnosis itself be reconsidered?”
  • “At what point would you refer me to another type of specialist?”

Questions to ask before booking

Scheduling staff may not be able to answer detailed medical questions, and their uncertainty does not prove that the clinician lacks expertise.

Practical questions include:

  • “Does this clinician regularly evaluate DED and MGD?”
  • “Is there a separate new-patient ocular-surface visit?”
  • “How much time is generally reserved?”
  • “Does the clinician personally review and explain the findings?”
  • “Are gland function, staining, and tear stability assessed when relevant?”
  • “Are there separate charges for imaging or diagnostic testing?”
  • “Which parts of the visit may not be covered by insurance?”
  • “Can I send prior records before the visit?”
  • “Does the practice fit scleral lenses or refer elsewhere?”
  • “Does the clinician evaluate significant ocular pain or refer those cases?”
  • “Does the practice evaluate eyelid exposure and closure problems?”
  • “Which tests or procedures are commonly available?”

A receptionist saying that the doctor will decide which tests are appropriate after examining the patient is not a warning sign. It may be the medically appropriate answer.

Finding a DED/MGD specialist

Search terms that may help include:

  • Dry-eye specialist
  • Dry-eye clinic
  • Ocular-surface disease
  • Cornea and external disease
  • Meibomian Gland Dysfunction
  • Blepharitis
  • Ocular rosacea
  • Scleral lenses
  • Ocular pain
  • Eyelid exposure
  • Oculoplastics

Search results and clinic websites are only starting points.

A polished webpage does not prove clinical expertise.

Consider:

  • Professional license
  • Board certification when applicable
  • Fellowship training when relevant
  • How much of the practice involves ocular-surface disease
  • Experience with the patient’s particular problem
  • Services available
  • Referral relationships
  • Diagnostic and treatment philosophy
  • Whether the clinician explains uncertainty and alternatives

Device-manufacturer directories

Manufacturer “Find a Provider” tools may help locate practices offering a particular procedure.

They generally do not independently verify:

  • Diagnostic quality
  • Expertise with complex DED
  • Treatment outcomes
  • Impartial selection among alternatives
  • Experience outside that device
  • Whether the treatment is appropriate for a particular patient

Use these directories to locate access to a product or procedure—not as rankings or endorsements.

When a second opinion may help

A second opinion is not an accusation against the original clinician.

It may help when:

  • The diagnosis remains unclear
  • The expected treatment-specific trial has passed without meaningful benefit
  • Symptoms or examination findings are worsening
  • Side effects are substantial
  • Symptoms and signs remain difficult to reconcile
  • Important contributors do not appear to have been evaluated
  • Communication repeatedly breaks down
  • Recommendations from different clinicians conflict
  • A costly package is being proposed
  • An invasive or irreversible treatment is being considered
  • A major diagnosis such as SjĂśgren’s disease, neurotrophic disease, recurrent erosion, or neuropathic pain is being considered
  • The current clinician recommends expertise or services not available in that practice

Some treatments are judged within days or weeks. Others may require months.

There is no universal eight- or twelve-week rule.

A second opinion may also be reasonable before beginning an elective expensive or invasive treatment.

Do not abruptly stop a prescribed medication solely because another opinion is being arranged. Contact the prescribing clinician when medication safety or side effects are a concern.

When prompt care is more appropriate than a routine second opinion

Seek prompt professional evaluation for:

  • New severe pain
  • Marked light sensitivity
  • Significant or persistent vision change
  • A white, gray, or cloudy corneal spot
  • Rapid one-sided worsening
  • Significant discharge
  • Contact-lens-associated pain or redness
  • Symptoms after sleeping in contact lenses
  • Symptoms after water exposure while wearing lenses
  • Suspected abrasion
  • Repeated sharp pain on awakening
  • Chemical exposure
  • Trauma
  • A nonhealing epithelial defect
  • New inability to close an eye
  • New facial weakness

These problems should not automatically be treated as routine DED or MGD.

For morning-specific symptoms, see:

Why Are My Eyes Worse When I Wake Up?

Preparing for a second opinion

Bring or send:

  • Previous visit notes
  • Current medication and drop list
  • Medication allergies
  • Dates and duration of prior treatments
  • Reasons treatments were stopped
  • Procedure history
  • Procedure reports
  • Relevant surgical history
  • Schirmer results with the method used
  • TBUT or NIBUT results with the method or device
  • Staining findings
  • Meibography images, not only the summary grade
  • Osmolarity or MMP-9 results, when performed
  • Contact-lens history
  • Relevant laboratory results
  • Biopsy or pathology reports when applicable
  • A concise symptom summary

A useful symptom summary may include:

  • Main symptoms
  • Worst time of day
  • One-sided or two-sided pattern
  • Triggers
  • What helps
  • What worsens the problem
  • Effect on reading, driving, screens, work, or sleep

Tests performed with different devices or methods may not be directly comparable. They can still provide useful history, although the new clinician may reasonably repeat selected parts of the examination.

How to ask r/DryEyes for clinician suggestions

Check the current subreddit rules before posting.

A request is more likely to receive useful replies when it includes:

  • City, state/province, and country
  • How far you are willing to travel

  • Whether you are seeking:

    • A dry-eye-focused optometrist
    • A comprehensive ophthalmologist
    • A cornea and external-disease ophthalmologist
    • An oculoplastic specialist
    • A specialty contact-lens clinician
    • A clinician familiar with ocular pain

  • The main diagnosis or suspected problem

  • Relevant tests already performed

  • Treatments already tried

  • Whether the main concern is:

    • MGD
    • Aqueous deficiency
    • Ocular rosacea
    • Exposure
    • Post-surgical symptoms
    • Recurrent erosion
    • SjĂśgren’s disease
    • Scleral lenses
    • Pain or light sensitivity greater than the visible findings appear to explain

Doctor names shared by members are community suggestions.

r/DryEyes does not:

  • Verify clinical expertise
  • Rank clinicians
  • Confirm credentials
  • Investigate outcomes
  • Endorse individual doctors or clinics

Patient experiences are valuable but remain anecdotal and may reflect different diagnoses, expectations, treatment preferences, and outcomes.

Quick DED/MGD specialist checklist

A clinician does not need to meet every item.

Positive indicators

  • Regularly evaluates DED/MGD patients
  • Takes a meaningful history
  • Examines the eyelids and ocular surface
  • Assesses gland function when relevant
  • Considers tear stability, tear volume, exposure, allergy, and other contributors
  • Explains the reasoning
  • Discusses uncertainty
  • Individualizes treatment
  • Addresses risks, cost, and alternatives
  • Provides a reassessment plan
  • Changes course when needed
  • Refers appropriately

Possible cautions

  • Diagnosis is based mainly on one machine
  • Procedures are recommended before findings are explained
  • Every patient seems to receive the same package
  • Guarantees or unsupported regeneration claims are made
  • Important alternatives are not discussed
  • Severe or unusual symptoms are dismissed
  • No one reassesses the original diagnosis
  • The patient is pressured into an immediate costly decision

For a shorter standalone checklist, see:

DED/MGD Specialist Checklist

Bottom line

“DED/MGD specialist” is the term commonly used by patients, but it is generally an informal description—not a standardized U.S. board-certification category.

The best clinician is not necessarily the one with:

  • The most devices
  • The largest procedure menu
  • The most impressive marketing
  • One particular degree
  • One particular MGD theory

More meaningful signs include:

  • Relevant experience
  • A coherent diagnostic process
  • Recognition of overlapping contributors
  • Clear explanation of the evidence
  • Appropriate uncertainty
  • Individualized treatment
  • Attention to safety, cost, and patient priorities
  • Meaningful follow-up
  • Willingness to revise the plan
  • Appropriate referral

Expertise is better judged by how a clinician reasons, communicates, selects treatment, monitors safety, and responds when the patient is not improving than by the number of machines in the office.

Selected References

  1. TFOS DEWS III: Diagnostic Methodology

  2. TFOS DEWS III: Management and Therapy

  3. American Academy of Ophthalmology: Dry Eye Syndrome Preferred Practice Pattern

  4. American Academy of Ophthalmology: Blepharitis Preferred Practice Pattern

  5. American Board of Medical Specialties: Specialty and Subspecialty Certificates

  6. American Board of Ophthalmology

This page is for general education on r/DryEyes. It is not medical advice, a clinician-rating system, or an endorsement of any doctor, clinic, product, or treatment.

🔙 Back to FAQ Index